Feed Top Reports Pricing

⌘K

07:03:27·37d

INSIDERFiling

SEC Form 3 filed by Enlivex Ltd.

ENLV· Enlivex Ltd.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

ENLV
Enlivex Ltd.
Health Care

Related

PR1d
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
SEC2d
SEC Form F-3 filed by Enlivex Ltd.
SEC3d
SEC Form 6-K filed by Enlivex Ltd.
PR3d
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
SEC16d
SEC Form 6-K filed by Enlivex Ltd.
PR16d
Ondo Global Markets Tokenizes Enlivex's Ordinary Shares
SEC29d
SEC Form 6-K filed by Enlivex Ltd.
PR29d
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022